1 Top Cannabis Stock I’d Buy Right Now

Here’s why investors looking to take advantage of U.S. legalization should consider Curaleaf (TSXV:CURA) today.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

A green rush into cannabis stocks is playing out today. Indeed, the cannabis sector continues to be among the hottest on the TSX right now.

The reason for this?

Well, legalization expectations in the U.S. are driving the growth prospects for these speculative investments higher. However, I think this catalyst is likely to be an uneven one, affecting various producers to various degrees.

Accordingly, here’s why Curaleaf Holdings (TSXV:CURA) remains one of my top cannabis picks today.

Excellent growth prospects

Boris Jordan, Curaleaf’s executive chairman, believes that marijuana legalization proceedings will not gain traction until Biden’s second term. However, there are expectations that cannabis legalization will eventually take hold south of the border.

Accordingly, companies like Curaleaf that are well positioned to take advantage of the growth prospects this provides should do better than domestic Canadian producers.

Why, you ask?

Well, unlike most TSX- or TSX Venture-traded cannabis companies, Curaleaf is a U.S. MSO. It’s entirely focused on the U.S. market and stands to be a direct beneficiary of such legislation. Curaleaf has operations coast to coast, and one of the most extensive networks in the U.S. among any cannabis player.

The company’s vertically integrated business model in the U.S. is also impressive. Curaleaf’s operations span the entire value chain. From cultivation to processing and retail sale, Curaleaf has built an impressive level of vertical integration in the U.S. market. This is unique among most Canadian-listed cannabis companies today.

The potential U.S. market growth has already manifested itself in the form of massive revenue growth of more than 200% year over year. Enough said.

Bottom line

Canadian producers looking to get into the U.S. market post-legalization may be too late. Companies like Curaleaf are building up massive networks and supply chains. Curaleaf’s vertically integrated model will be nearly impossible (or at least, extremely expensive) to replicate.

Accordingly, I’d stick with the winners in the U.S. market for those looking for exposure to this key catalyst.

I see the entry fee into the U.S. cannabis market as one that’s already extremely high. It’s only going to get higher should legalization legislation materialize. The Canadian market is great, but it’s still tiny relative to the growth potential the U.S. can provide.

Curaleaf’s valuation relative to Canadian cannabis players remains attractive. Given the outsized growth potential of Curlaef relative to its Canadian peers, the decision here is clear. Curaleaf is a winner in the cannabis space and is my only pick in this sector right now for investors looking to capitalize on U.S. legalization.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Monday, May 30

TSX investors should keep a close eye on the latest manufacturing data from China today.

Read more »